Showing results (261-270 of 727) with videos related to
Sort By:
Pageof 73
Studies in Health Technology and Informatics|September 7, 2011
Healthcare professionals' experiences with EHR-system access control mechanismsArild Faxvaag, Trond S Johansen, Vigdis Heimly, et al.Journal of Immunological Methods|July 6, 1984
Solid-phase radioimmunoassay of immunoglobulins G, A and M: applicability in analysis of sucrose gradientsE F Eriksen, H Danielsen, A S Johansen, et al.Plos One|September 19, 2014
The mechanisms of plant cell wall deconstruction during enzymatic hydrolysisLisbeth G Thygesen, Emil E Thybring, Katja S Johansen, et al.International Journal of Cancer|December 25, 2019
Antitumour immunity invoked by hepatic arterial infusion of first-line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8-12 years of follow-upHanna Abrahamsson, Benny V Jensen, Lise L Berven, et al.Clinical and Experimental Immunology|April 6, 2005
Circulating YKL-40 levels during human endotoxaemiaJ S Johansen, K S Krabbe, K Møller, et al.Archives of Orthopaedic and Trauma Surgery|January 1, 1992
Types I and III procollagen extension peptides in serum respond to fracture in humansS Joerring, L T Jensen, G R Andersen, et al.Public Health|February 14, 2024
Evaluation of a community helpers' mental health and suicide awareness training programme for youth and young adults in Alberta, CanadaC C Loitz, F Arinde, F Olaoye, et al.The European Respiratory Journal|March 28, 2009
Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smokingT B Grydeland, A Dirksen, H O Coxson, et al.Nordic Journal of Psychiatry|October 22, 2022
Time trends in co-occurring substance use and psychiatric illness (dual diagnosis) from 2000 to 2017 - a nationwide study of Danish register dataSolvej Mårtensson, Signe W Düring, Katrine S Johansen, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancerJ S Johansen, C Cintin, M Jørgensen, et al.Pageof 73